Resultados de la búsqueda 351-360 of 16647 for Enzyme replacement therapy
Entre las afecciones aprobadas por la Administración de Alimentos y Medicamentos de Estados Unidos (FDA, por sus siglas en inglés) para el tratamiento de ...
These advancements provide the opportunity for more detailed analyses of batting motions that can be integrated into the evaluation and treatment of ...
The primary goal of the registry is characterizing patterns of use for NSCLC therapy. REVOLUTION will be a multicenter registry enrolling approximately 2,500 ...
Experts at Mayo Clinic Comprehensive Cancer Center use CAR-T cell therapy to treat several types of cancer, including acute lymphoblastic leukemia, ...
... treatment in patients with short bowel syndrome (SBS). ... GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing ...
... treatment (refractory). Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death.
... therapy have more hair loss than patients who are not getting such. ... enzymes needed for cell growth. Giving rituximab together with romidepsin and lenalidomide ...
The goal of this study is to collect adipose tissue from healthy and disease patients to understand the biology and potential therapeutic use of mesenchymal ...
Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?